May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
May 15, 2014 — CathMaps demonstrated how mobile technology can provide emergency assistance and peace of mind to ...
May 14, 2014 — Detroit Medical Center (DMC) Harper Hospital presented a live CorPath robotic-assisted percutaneous ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 9, 2014 — InspireMD Inc. initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS ...
May 7, 2014 — Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral ...
May 7, 2014 — GE Healthcare received U.S. Food and Drug Administration (FDA) clearance for its Discovery IGS 740, a new ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
May 6, 2014 — Technology’s newest tool and its potential to improve patient care will be the focus of a first-of-its ...
May 6, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the Artis one angiogr ...
May 2, 2014 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the late-breaking clinic al ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe ...
May 2, 2014 — Terso Solutions Inc., a provider of automated inventory management solutions for healthcare and life ...
May 1, 2014 — Volcano Corp. announced the commencement of its limited market release of its U.S. Food and Drug ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
April 22, 2014 — Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary Instant ...
April 21, 2014 — Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) ...
April 18, 2014 — A University of California, San Diego scientist has developed a new biomaterial that could potentially ...
May 16, 2014